Compare VERA & CHRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERA | CHRN |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.2B |
| IPO Year | 2021 | N/A |
| Metric | VERA | CHRN |
|---|---|---|
| Price | $42.43 | $18.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $81.30 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 448.3K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $472.48 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.07 | $15.74 |
| 52 Week High | $56.05 | $28.20 |
| Indicator | VERA | CHRN |
|---|---|---|
| Relative Strength Index (RSI) | 59.68 | 25.27 |
| Support Level | $40.87 | $15.74 |
| Resistance Level | $43.30 | $23.52 |
| Average True Range (ATR) | 2.62 | 3.18 |
| MACD | 0.37 | -0.69 |
| Stochastic Oscillator | 68.92 | 18.90 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
ChronoScale Corp is focused on providing computing infrastructure for artificial intelligence workloads. It offers GPU-based infrastructure for AI training, inference, and high-performance computing.